Paclitaxel in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Maurie Markman, MD
The Cleveland Clinic
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
44 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Ccop - Western Regional, Arizona
Phoenix, Arizona, United States
- Women'S Cancer Center at Community Hospital of Los Gatos
Los Gatos, California, United States
- Chao Family Comprehensive Cancer Center at University of California Irvine Cancer Center
Orange, California, United States
- Ccop - Christiana Care Health Services
Newark, Delaware, United States
- Mbccop - Hawaii
Honolulu, Hawaii, United States
- Mbccop - University of Illinois at Chicago
Chicago, Illinois, United States
- Rush-Presbyterian-St. Luke'S Medical Center
Chicago, Illinois, United States
- Ccop - Evanston
Evanston, Illinois, United States
- Memorial Medical Center
Springfield, Illinois, United States
- Ccop - Carle Cancer Center
Urbana, Illinois, United States
- Indiana University Cancer Center
Indianapolis, Indiana, United States
- Saint Joseph Regional Medical Center
South Bend, Indiana, United States
- Holden Comprehensive Cancer Center at University of Iowa
Iowa City, Iowa, United States
- Markey Cancer Center at University of Kentucky Chandler Medical Center
Lexington, Kentucky, United States
- Warren Grant Magnuson Clinical Center - Nci Clinical Studies Support
Bethesda, Maryland, United States
- Ccop - Michigan Cancer Research Consortium
Ann Arbor, Michigan, United States
- Ccop - Grand Rapids
Grand Rapids, Michigan, United States
- Ccop - Kalamazoo
Kalamazoo, Michigan, United States
- Ccop - Metro-Minnesota
Saint Louis Park, Minnesota, United States
- Keesler Medical Center - Keesler Air Force Base
Keesler Air Force Base, Mississippi, United States
- Ellis Fischel Cancer Center at University of Missouri - Columbia
Columbia, Missouri, United States
- Ccop - Kansas City
Kansas City, Missouri, United States
- Ccop - Cancer Research for the Ozarks
Springfield, Missouri, United States
- Ccop - Missouri Valley Cancer Consortium
Omaha, Nebraska, United States
- Roswell Park Cancer Institute
Buffalo, New York, United States
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
Chapel Hill, North Carolina, United States
- Duke Comprehensive Cancer Center
Durham, North Carolina, United States
- Comprehensive Cancer Center at Wake Forest University
Winston-Salem, North Carolina, United States
- Charles M. Barrett Cancer Center at University Hospital
Cincinnati, Ohio, United States
- Cleveland Clinic Taussig Cancer Center
Cleveland, Ohio, United States
- Ireland Cancer Center
Cleveland, Ohio, United States
- Arthur G. James Cancer Hospital - Ohio State University
Columbus, Ohio, United States
- Ccop - Columbia River Oncology Program
Portland, Oregon, United States
- Abington Memorial Hospital
Abington, Pennsylvania, United States
- Ccop - Geisinger Clinic and Medical Center
Danville, Pennsylvania, United States
- Penn State Cancer Institute at Milton S. Hershey Medical Center
Hershey, Pennsylvania, United States
- Fox Chase Cancer Center
Philadelphia, Pennsylvania, United States
- Magee-Womens Hospital
Pittsburgh, Pennsylvania, United States
- Southeast Gynecologic Oncology Associates
Knoxville, Tennessee, United States
- Genecologic Oncology Network
Nashville, Tennessee, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jul 2001
- Primary completion
- 30 Apr 2006
- Completion
- —
- Last update posted
- 11 Apr 2013
- Registered enrollment
- —
- Registry id
- NCT00023907
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.